Fundraising FoxAlta Partners — 2016 Investments
3 investments dated 2016 · listed companies and verified rows first · show all
Prolacta Bioscience manufactures 100% human milk-based nutritional products and fortifiers for premature and critically ill infants in hospital neonatal intensive care units.
BiotechHealthtechMedical DevicesCity Of Industry, US
Scott Elster(Executive Officer, Director)inJohn M. Shields(Executive Officer)in
BoardFrank Foster(Director)Martin Sutter(Director)David Brailer(Director)
Board seatDan Janney· per SEC Form D
Co-investorsAisling CapitalEssex Woodlands Healthcare PartnersFrontier Venture CapitalPROOF
South San Francisco biotech engineering commensal gut bacteria into controllable live therapeutics for chronic diseases.
Daly City, US
Weston Whitaker(Executive Officer, Director, Promoter)William DeLoache(Director)Samuel Smits(Director)
BoardElizabeth Stanley(Director)
Co-investorsCerity Partners VenturesColorcon Ventures5AM VenturesAlexandriaDCVC (Data Collective)DCVC Bio+2 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.